All In Biotech

Drug Trial Radar · NCT03068741

Paramedic Initiated Treatment of Sepsis Targeting Out-of-hospital Patients (PITSTOP)

Last checked: Nov 19, 2026Latest source record: Apr 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 2,061 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,061

Actual

Start

Mar 23, 2020

Primary completion

Nov 17, 2025

Study completion Nov 17, 2025

Sponsor

Lead sponsor
Dr. Damon ScalesAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Canadian Institutes of Health Research (CIHR); Sunnybrook Research Institute
First posted
Mar 3, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Factorial
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Sepsis occurs when a serious infection - most commonly infection of the lungs, urinary system, or blood - leads to acute organ failure. It is a common, expensive, and frequently lethal condition. A growing body of evidence suggests that early recognition and treatment of sepsis can improve survival. Unfortunately, many patients with sepsis do not receive key therapies until physicians working in Emergency Departments have assessed them - often introducing marked delays. It is estimated that one-half of patients with sepsis are treated and transported to hospital by paramedics. This allows paramedics a unique opportunity to provide early treatment at the initial point of patient contact, thereby decreasing the time to treatment for these critically ill patients. This randomized controlled trial will evaluate whether prompt recognition followed by early antibiotics and/or intravenous fluids delivered by paramedics in the field leads to improved survival, compared to usual care, for patients who are transported to the hospital with sepsis.

Conditions

  • Severe Sepsis or Septic Shock

Interventions

  • Comparison 1: Prehospital CeftriaxoneDrug

    Paramedics will administer 1g of intramuscular ceftriaxone.

  • Comparison 1: PlaceboDrug

    Paramedics will administer an identical volume of reconstituted intramuscular placebo.

  • Comparison 2: Liberal fluidsDrug

    Paramedics will administer up to 2 litres of intravenous saline (0.9%) to all patients regardless of systolic blood pressure, and reassessing this infusion after each 250ml are infused.

  • Comparison 2: Conservative fluidsDrug

    Paramedics will administer intravenous saline (0.9%) according to the Medical Directive, which allows for infusion of fluids if systolic blood pressure is \<90mmHg and continued until systolic blood pressure is \>=100mmHg.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary outcome: mortality prior to hospital discharge to day 90.Time frame: 90 days

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Halton Region Paramedic Services

    Toronto, Ontario, Canada

  • Peel Region Paramedic Services

    Toronto, Ontario, Canada

  • Toronto Paramedic Services

    Toronto, Ontario, Canada

  • York Region Paramedic Services

    Toronto, Ontario, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.